Bora CDMO Bora CDMO

X

Find Sodium Pantothenate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
51
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Sodium Pantothenate
Also known as: 867-81-2, Sodium d-pantothenate, Sodium (r)-3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoate, D-pantothenic acid sodium, D-pantothenic acid sodium salt, Pantothenate sodium
Molecular Formula
C9H16NNaO5
Molecular Weight
241.22  g/mol
InChI Key
GQTHJBOWLPZUOI-FJXQXJEOSA-M
FDA UNII
OES0R93F0C

1 2D Structure

Sodium Pantothenate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate
2.1.2 InChI
InChI=1S/C9H17NO5.Na/c1-9(2,5-11)7(14)8(15)10-4-3-6(12)13;/h7,11,14H,3-5H2,1-2H3,(H,10,15)(H,12,13);/q;+1/p-1/t7-;/m0./s1
2.1.3 InChI Key
GQTHJBOWLPZUOI-FJXQXJEOSA-M
2.1.4 Canonical SMILES
CC(C)(CO)C(C(=O)NCCC(=O)[O-])O.[Na+]
2.1.5 Isomeric SMILES
CC(C)(CO)[C@H](C(=O)NCCC(=O)[O-])O.[Na+]
2.2 Other Identifiers
2.2.1 UNII
OES0R93F0C
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 867-81-2

2. Sodium D-pantothenate

3. Sodium (r)-3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoate

4. D-pantothenic Acid Sodium

5. D-pantothenic Acid Sodium Salt

6. Pantothenate Sodium

7. Sodium Pantothenic Acid

8. D-pantothenic Acid (sodium)

9. Pantothenic Acid, Monosodium Salt, D-

10. Oes0r93f0c

11. Sodium;3-[[(2r)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate

12. D-pantothenate Sodium

13. Mfcd00002767

14. Unii-oes0r93f0c

15. Pantothenic Acid, Sodium Salt

16. Ccris 1905

17. Hsdb 760

18. Vitamin B5 Sodium

19. Einecs 212-768-6

20. Sodium Pantothenate,(s)

21. Pantothenic Acid Sodium Salt

22. Dsstox_cid_27173

23. Dsstox_rid_82171

24. Dsstox_gsid_47173

25. Panthothenic Acid Sodium Salt

26. Schembl124920

27. Dtxsid4047173

28. Hy-b0430a

29. Hms2093p20

30. Sodium Pantothenate [hsdb]

31. Sodium Pantothenate [inci]

32. Tox21_302487

33. Pantothenate Sodium [who-dd]

34. Sodium N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-beta-alanine, (r)-

35. Ccg-213530

36. Cs-5150

37. Beta-alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, Monosodium Salt, (r)-

38. Ncgc00256852-01

39. Cas-867-81-2

40. Pantothenic Acid Sodium Salt [mi]

41. P0013

42. D11519

43. O12072

44. Q-201535

45. Q27285618

46. Beta-alanine, N-((2r)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, Monosodium Salt

47. Beta-alanine, N-((2r)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, Sodium Salt (1:1)

48. .beta.-alanine, N-((2r)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, Sodium Salt (1:1)

2.4 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 241.22 g/mol
Molecular Formula C9H16NNaO5
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count6
Exact Mass241.09261689 g/mol
Monoisotopic Mass241.09261689 g/mol
Topological Polar Surface Area110 Ų
Heavy Atom Count16
Formal Charge0
Complexity244
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Therapeutic Uses

Topical application of pantothenate is widely used in clinical practice for wound healing.

Wiederholt T et al; Exper Dermatol 18 (11): 969-78 (2009). Available from, as of March 16, 2010: https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19397697


5 Pharmacology and Biochemistry
5.1 Absorption, Distribution and Excretion

Distribution of pantothenate from plasma into liver was very rapid; during 10 min after iv admin about 80% of dose was cleared from plasma.

PMID:1265350 Taylor T et al; Res Vet Sci 20 (2): 151-4 (1976).


Total blood pantothenic acid levels were higher after oral admin of 21.6 uM/kg pantethine than after calcium pantothenate in rats but no difference in amount of bound pantothenic acid. Max concentrations were observed at 2-4.5 hr after ingestion of both groups.

Ono S et al; J Nutr Sci Vitaminol 20(3) 203 (1974)


Total pantothenic acid excretions after 24 hr oral admin to rats were 29% and 18% after administration of pantethine and calcium pantothenate, respectively. Pantethine was more readily absorbed from GI tract than calcium pantothenate.

Ono S et al; J Nutr Sci Vitaminol 20(3) 203 (1974)


5.2 Mechanism of Action

... To test the functional effect of pantothenate on dermal fibroblasts, cells were cultured and in vitro proliferation tests were performed using a standardized scratch test procedure. For all three donors analyzed, a strong stimulatory effect of pantothenate at a concentration of 20 ug/mL on the proliferation of cultivated dermal fibroblasts was observed. To study the molecular mechanisms resulting in the proliferative effect of pantothenate, gene expression was analyzed in dermal fibroblasts cultivated with 20 ug/mL of pantothenate compared with untreated cells using the GeneChip Human Exon 1.0 ST Array. A number of significantly regulated genes were identified including genes coding for interleukin (IL)-6, IL-8, Id1, HMOX-1, HspB7, CYP1B1 and MARCH-II. Regulation of these genes was subsequently verified by quantitative real-time polymerase chain reaction analysis. Induction of HMOX-1 expression by pantothenol and pantothenic acid in dermal cells was confirmed on the protein level using immunoblots. Functional studies revealed the enhanced suppression of free radical formation in skin fibroblasts cultured with panthenol. In conclusion, these studies provided new insight in the molecular mechanisms linked to the stimulatory effect of pantothenate and panthenol on the proliferation of dermal fibroblasts. /Calcium pantotenate/

Wiederholt T et al; Exper Dermatol 18 (11): 969-78 (2009). Available from, as of March 16, 2010: https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19397697


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY